THE TREATMENT OF HYPERTENSION WITH DRUGS
Authors: M MENDLOWITZ
Journal: Annals of Internal Medicine (1953)

Article1 November 1953THE TREATMENT OF HYPERTENSION WITH DRUGSMILTON MENDLOWITZ, M.D., F.A.C.P.MILTON MENDLOWITZ, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-39-5-999 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThere are times when the strident conflicts of investigators, the rise and fall of theories and the babel of unsorted evidence create such a sense of confusion in a field that an atmosphere of frustration and despair prevails in which no one believes anything; this has happened to some extent in hypertension.1, 2Yet somewhere between the extreme skepticism both of the very young and of the old and tired, and the transient enthusiasms of the protagonists of this theory or that remedy, lies a middle groundxd of achievement and even agreement. It is generally agreed, for example, that the...Bibliography1. Goldblatt H: Introductory remarks: factors regulating blood pressure, Transactions of the Fifth Conference, Edited by B. W. Zweifach and E. Shorr, 1951, Josiah Macy, Jr. Foundation, New York. Google Scholar2. Schroeder HA: Pathogenesis of hypertension, Am. J. Med. 10: 189, 1951. CrossrefMedlineGoogle Scholar3. Pickering GW: The peripheral resistance in persistent arterial hypertension, Clin. Sc. 2: 209, 1936. Google Scholar4. PrinzmetalWilson MC: Nature of peripheral resistance in arterial hypertension with special reference to vasomotor system, J. Clin. Investigation 15: 63, 1936. CrossrefMedlineGoogle Scholar5. Smithwick RH: The role of the sympathetic nervous system in essential hypertension in man, Angiology 2: 227, 1951. CrossrefMedlineGoogle Scholar6. Mendlowitz M: Shifting horizons in hypertension, Medicine Illus. 5: 409, 1951. Google Scholar7. Mendlowitz M: Digital blood flow, arterial pressure, and vascular resistance in arterial hypertension and in coronary thrombosis, J. Clin. Investigation 21: 539, 1942. CrossrefMedlineGoogle Scholar8. GoldenbergPinesBaldwinGreeneRoh MKLEDDGCE: The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension, Am. J. Med. 5: 792, 1948. CrossrefMedlineGoogle Scholar9. CorcoranKohlstaedtPage ACKAIH: Changes of arterial blood pressure and renal hemodynamics by injection of angiotonin in human beings, Proc. Soc. Exper. Biol. and Med. 46: 244, 1941. CrossrefGoogle Scholar10. GrollmanMuirheadVanatta AEEJ: Role of the kidney in pathogenesis of hypertension as determined by a study of the effects of bilateral nephrectomy and other experimental procedures on the blood pressure of the dog, Am. J. Physiol. 157: 21, 1949. CrossrefMedlineGoogle Scholar11. PereraFlemingPinesCrymble GATCKLM: Cortisone in hypertensive disease, J. Clin. Investigation 29: 739, 1950. CrossrefMedlineGoogle Scholar12. KnowltonLoebStoerckHerbertWhiteHeffernan AIENHCCJPJF: Induction of arterial hypertension in normal and adrenalectomized rats given cortisone acetate, J. Exper. Med. 96: 187, 1952. CrossrefMedlineGoogle Scholar13. RaabHumphreysLepeschkin WRJE: Potentiation of pressor effects of nor-epinephrine and epinephrine in man by desoxycorticosterone acetate, J. Clin. Investigation 29: 1397, 1950. CrossrefMedlineGoogle Scholar14. PageMcCubbin IHJW: Influence of thyroidal function on vascular reactivity in dogs, Circulation 5: 390, 1952. CrossrefMedlineGoogle Scholar15. RosenmanFreedFriedman RHSCM: The peripheral vascular reactivity of potassium deficient rats, Circulation 5: 412, 1952. CrossrefMedlineGoogle Scholar16. Grimson KS: Sympathectomy and circulation—anatomic and physiologic considerations and early and late limitations, Surgery 19: 277, 1946. MedlineGoogle Scholar17. MendlowitzTouroff MAS: The effect of sympathectomy for essential hypertension on the hallucal circulation, Circulation 5: 577, 1952. CrossrefMedlineGoogle Scholar18. Richards RL: The peripheral circulation in health and disease, 1946, E. S. Livingstone, Ltd., Edinburgh. Google Scholar19. Heymans C: The pressoreceptive mechanisms for the regulation of heart rate, vasomotor tone, blood pressure and blood supply. Experimental arterial hypertension. Role of the cardioaortic and carotid sinus nerves in the reflex control of the respiratory center, New England J. Med. 219: 147, 1938. CrossrefGoogle Scholar20. JessarHorwitzMontgomery RAOH: The vasodilating effects of intravenous procaine in patients with ischemic extremities, Am. J. M. Sc. 224: 300, 1952. CrossrefMedlineGoogle Scholar21. KrantzCarr JCCJ: The pharmacologic principles of medical practice, 1951, The Williams and Wilkins Co., Baltimore. Google Scholar22. Salter WT: A textbook of pharmacology, 1952, W. B. Saunders, Philadelphia. Google Scholar23. Vakil RJ: A clinical trial of Rauwolfia serpentina in essential hypertension, Brit. Heart J. 11: 350, 1949. CrossrefMedlineGoogle Scholar24. FreisStantonCulbertsonLitterHalperinBurnettWilkins EDJRJWJMHCHRW: The hemodynamic effects of hypertensive drugs in man. I. Veratrum viride, J. Clin. Investigation 28: 353, 1949. CrossrefGoogle Scholar25. FreisStanton EDJR: A clinical evaluation of veratrum viride in the treatment of essential hypertension, Am. Heart J. 36: 723, 1948. CrossrefMedlineGoogle Scholar26. Wilkins RW: Veratrum viride and essential hypertension, New England J. Med. 242: 535, 1950. CrossrefGoogle Scholar27. HooblerCorleyKabzaLoyke SWRWTGHF: Treatment of hypertension with oral protoveratrine, Ann. Int. Med. 37: 465, 1952. LinkGoogle Scholar28. Röthlin E: The pharmacology of the natural and dihydrogenated alkaloids of ergot, Bull. Schweiz. Acad. d. med. Wchnschr. 2: 249, 1947. MedlineGoogle Scholar29. StollHoffman AA: Die Alkaloide der Ergotoxingruppe: Ergocristin, Ergokryptin und Ergocornin, Helvet. chem. acta 26: 1570, 1943. CrossrefGoogle Scholar30. BarcroftKonzettSwan HHHJ: Observations on the action of hydrogenated alkaloids of the ergotoxin group on the circulation in man, J. Physiol. 112: 273, 1951. CrossrefMedlineGoogle Scholar31. Schroeder HA: Effects on hypertension of sulfhydryl and hydrazine compounds, J. Clin. Investigation 30: 672, 1951. Google Scholar32. FreisFinnerty EDFA: Suppression of vasomotor reflexes in man following 1-hydrazinophthalazine (C-5968), Proc. Soc. Exper. Biol. and Med. 75: 23, 1950. CrossrefMedlineGoogle Scholar33. SouthworthRussek JLHI: A technique for testing hypertensive patients preoperatively, Ann. Surg. 125: 119, 1947. CrossrefMedlineGoogle Scholar34. La DueMurisonPack JSPJGT: The use of tetraethylammonium bromide as a diagnostic test for pheochromocytoma, Ann. Int. Med. 29: 914, 1948. LinkGoogle Scholar35. MoeRennickHooblerNelighLyons GKBSWRBRH: Evaluations of vasomotor tone in animal and man by means of tetraethylammonium ion, Proc. Central Soc. Clin. Research 19: 5, 1946; also J. Lab. and Clin. Med. 32: 311, 1947. MedlineGoogle Scholar36. HooblerAvera SWJW: Effect of sympathetic blocking procedures and of sympathectomy on peripheral blood flow, Federation Proc. 8: 77, 1949. Google Scholar37. HooblerMaltonBallantineCohenNelighPeetLyons SWSDHTSRBMMRH: Studies on vasomotor tone. 1. The effect of the tetraethylammonium ion on the peripheral blood flows of normal subjects, J. Clin. Investigation 28: 638, 1949. CrossrefGoogle Scholar38. McLemoreGreenLide GAHDTH: Respiratory complication from tetraethylammonium ion, Circulation 4: 47, 1951. CrossrefMedlineGoogle Scholar39. SarnoffGoodaleSarnoff SJWTLC: Graded reduction of arterial pressure in man by means of a thiophanium derivative (Ro 2-2222). Preliminary observations on its effect in acute pulmonary edema, Circulation 6: 63, 1952. CrossrefMedlineGoogle Scholar40. LonginoGrimsonChittumMetcalf FHKSJRBH: Effects of a new quaternary amine and a new imidazoline derivative on the autonomic nervous system, Surgery 26: 421, 1949. MedlineGoogle Scholar41. BeinMeier HJR: Pharmakologische Untersuchungen über Pendiomid, eine neuartige Substanz mit Ganglienblockierender Wirkung, Schweiz. med. Wchnschr. 81: 446, 1951. MedlineGoogle Scholar42. PatonZaimis WDEG: Clinical potentialities of certain bisquaternary salts causing neuromuscular and ganglionic block, Nature, London 162: 810, 1948. CrossrefMedlineGoogle Scholar43. ArnoldGoetzRosenheim PRHML: Effect of pentamethonium on the peripheral circulation, Lancet 2: 408, 1949. CrossrefMedlineGoogle Scholar44. BurtGraham CCAJ: Pentamethonium and hexamethonium iodide in investigation of peripheral vascular disease and hypertension, Brit. M. J. 1: 455, 1950. CrossrefMedlineGoogle Scholar45. SmirkAlstad FHKS: Treatment of arterial hypertension by penta- and hexamethonium salts, Brit. M. J. 1: 1217, 1951. CrossrefMedlineGoogle Scholar46. CampbellRobertson AE: Treatment of severe hypertension with hexamethonium bromide, Brit. M. J. 2: 804, 1950. CrossrefMedlineGoogle Scholar47. FinnertyFreis FAED: Experimental and clinical evaluation in man of hexamethonium (C 6), a new ganglionic blocking agent, Circulation 2: 828, 1950. CrossrefMedlineGoogle Scholar48. FreisFinnertySchnaperJohnson EDFAHWRL: The treatment of hypertension with hexamethonium, Circulation 5: 20, 1952. CrossrefMedlineGoogle Scholar49. Schroeder HA: The effect of 1-hydrazinophthalazine and hexamethonium on hypertension, J. Lab. and Clin. Med. 38: 949, 1951. Google Scholar50. GrimsonOrgainRoweSieber KSESCRHA: Caution with regard to use of hexamethonium and "Apresoline," J. A. M. A. 149: 215, 1952. CrossrefMedlineGoogle Scholar51. HaimoviciMedinets HHE: Effect of Dibenamine on blood pressure in normotensive and hypertensive subjects, Proc. Soc. Exper. Biol. and Med. 67: 163, 1948. CrossrefMedlineGoogle Scholar52. HaimoviciMoserKrankower HMH: The effect of oral 688 A on blood pressure in normotensive and hypertensive subjects, Proc. Soc. Exper. Biol. and Med. 77: 477, 1951. CrossrefMedlineGoogle Scholar53. MoserWaltersMasterTaymorMetreux MMAMRCJ: Chemical blockade of the sympathetic nervous system in essential hypertension, Arch. Int. Med. 89: 708, 1952. CrossrefGoogle Scholar54. EmletGrimsonBellOrgain JRKSDMES: Use of Piperoxan and Regitine as routine tests in patients with hypertensions, J. A. M. A. 146: 1833, 1951. Google Scholar55. GiffordRothKvale RWGMWF: The evaluation of use of Regitine (C 7337) as a new pharmacologic test for pheochromocytoma, J. Lab. and Clin. Med. 38: 812, 1951. Google Scholar56. GrimsonReardonMarxoniHendrix KSMJFAJP: The effects of Priscol (2-benzyl, 4,5 imidazoline HCl) on peripheral vascular diseases, hypertension and circulation in patients, Ann. Surg. 127: 968, 1948. CrossrefGoogle Scholar57. GoldenbergSnyderAranow MCHH: New test for hypertension due to circulating epinephrine, J. A. M. A. 135: 971, 1947. CrossrefMedlineGoogle Scholar58. WatkinFroebHatchGutman DMHFFTAB: Results with unmodified Kempner rice diet in 50 hospitalized patients, Am. J. Med. 9: 441, 1950. CrossrefMedlineGoogle Scholar59. EurmanMendlowitz GHM: The effect of low sodium diet and drugs on the digital vascular resistance, in manuscript. Google Scholar60. PinesPerera KLGG: Thiocyanate effect on sodium excretion in normotensive and hypertensive subjects, Proc. Soc. Exper. Biol. and Med. 81: 149, 1952. CrossrefMedlineGoogle Scholar61. Mendlowitz M: Digital vascular resistance in normal, polycythemic and hypertensive states, Circulation 3: 694, 1951. CrossrefMedlineGoogle Scholar62. Mendlowitz M: Observations on the calorimetric method for measuring digital blood flow, Angiology 1: 247, 1950. CrossrefMedlineGoogle Scholar63. DrollerPembertonRosemanGrout HJCJL: High blood pressure in the elderly, Brit. M. J. 2: 968, 1952. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication April 8, 1953.From the Department of Medicine, The Mount Sinai Hospital, New York, N. Y. Aided by a grant from the National Heart Institute, Department of Health, Welfare and Education, Washington, D. C. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCurrent treatment of hypertension with drugsPharmacology of Antihypertensive CompoundsHypertonieHypertonieDrug therapy in primary hypertension in relation to the severity of the diseaseThe Alkaloids of Rauwolfia Serpentina Benth* 1 November 1953Volume 39, Issue 5Page: 999-1013KeywordsClinical trialsDietDrugsFallsHeartHospital medicineHypertensionSodium ePublished: 1 December 2008 Issue Published: 1 November 1953 PDF downloadLoading ...